FindTrial
Sign In

pleurodesis

PROCEDURE5 trials

Sponsors

Oxford University Hospitals NHS Trust, Grupo de Pesquisa em Pleura e Oncologia Toracica, Rolf Inderbitzi, Assiut University, University of Health Sciences Lahore

Conditions

Malignant Pleural EffusionMalignant Pleural Effusions (Mpe)Metastatic CancerPleural Effusion, MalignantPleurodesisPneumothorax Spontaneous PrimaryPneumothorax Spontaneous Secondary

Early Phase 1

The Outcome of Inserting Intercostal Tube or Pleurodesis for Malignant Pleural Effusion
Not yet recruitingNCT06742099
Assiut UniversityMalignant Pleural Effusions (Mpe)
Start: 2024-12-30End: 2025-09-30Target: 20Updated: 2024-12-19

Phase 2

Ibuprofen or Morphine in Treating Pain in Patients Undergoing Pleurodesis for Malignant Pleural Effusion
NCT00644319
Oxford University Hospitals NHS TrustMetastatic Cancer
Start: 2007-03-31Target: 320Updated: 2009-07-08

Phase 4

Safety Profile of Iodopovidone as an Agent for Pleurodesis in Malignant Pleural Effusion
CompletedNCT01670786
Grupo de Pesquisa em Pleura e Oncologia ToracicaPleural Effusion, Malignant
Start: 2010-01-31End: 2013-07-31Updated: 2014-05-13

Unknown Phase

Malignant Pleural Effusion: Pleur-X vs. Chemical Pleurodesis in VATS
NCT03518788
Rolf InderbitziMalignant Pleural Effusion
Start: 2018-01-25End: 2020-12-31Target: 234Updated: 2018-05-08
Comparison of Talc Slurry Versus Talc Insufflation: A Study on Effectiveness, Safety, and Hospital Outcomes in Pleurodesis
Not yet recruitingNCT07167992
University of Health Sciences LahorePleural Effusion, Malignant, Pleurodesis, Pneumothorax Spontaneous Primary +1
Start: 2026-02-01End: 2027-03-30Target: 160Updated: 2026-01-06
Comparison of Talc Slurry Versus Talc Insufflation: A Study on Effectiveness, Safety, and Hospital Outcomes in Pleurodesis
Not yet recruitingNCT07167992
University of Health Sciences LahorePleural Effusion, Malignant, Pleurodesis, Pneumothorax Spontaneous Primary +1
Start: 2026-02-01End: 2027-03-30Target: 160Updated: 2026-01-06